{"entity":{"id":"isp-chile","kind":"institution","name":"Instituto de Salud Pública de Chile (ISP)","aka":["ISP","ISPCH","Chilean Public Health Institute","Chilean medicines regulator"],"tldr":"Chile's medicines regulator and national reference laboratory. It registers medicines within six months by the ordinary route, and since 2020 within three months for a medicine already registered for the same use by a stringent regulator; biological medicines are excluded from that fast route unless the Minister exempts them.","summary":"The Instituto de Salud Pública states that its origins go back to the Instituto de Higiene of 1892 and the Instituto Bacteriológico de Chile of 1939, which became the ISP in 1979, and that since 2016 the Pan American Health Organization has certified it as a level 4 regional reference regulatory authority for medicines. Under the Código Sanitario no medicine may be distributed in Chile without registration, and the ISP keeps the register.\n\nDecreto 3 de 2010, the regulation of the national system for controlling medicines, sets a total of six months from payment of the fee for the ordinary registration route (article 47), and five months for its simplified route (article 52). Decreto 54 de 2019, published on 21 August 2020, added an accelerated route (articles 54 A to 54 G) for medicines registered for the same indication by a high-surveillance regulator, defined as a WHO-listed stringent regulatory authority, a PAHO level IV authority or a PIC/S member: the applicant files the dossier given to that regulator, the ISP takes its review into account, and the procedure may not exceed three months unless the applicant must correct the file. It is closed to medicines refused by any such agency and, unless the Minister of Health exempts them by resolution, to biological medicines. Article 21 lets the ISP authorise use of an unregistered medicine in urgent shortage, for personal import or for a clinical trial. OnCo did not find published measured approval times for cancer medicines. The coordinates are a Santiago city point.","asOf":"2026-11-11","links":[{"label":"ISP: who we are (Spanish)","url":"https://www.ispch.gob.cl/quienes-somos/"},{"label":"Decreto 3 de 2010, articles 21, 47 and 52 (LeyChile, Spanish)","url":"https://www.bcn.cl/leychile/navegar?idNorma=1026879"},{"label":"Decreto 54 de 2019, accelerated registration route (LeyChile, Spanish)","url":"https://www.bcn.cl/leychile/navegar?idNorma=1148609"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["minsal-chile"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Santiago","country":"CL","lat":-33.45,"lng":-70.66,"institutionType":"government","website":"https://www.ispch.gob.cl","programs":["Registration of medicines (ordinary, simplified and accelerated routes)","Authorisation of unregistered medicines for urgent use and clinical trials","National reference laboratories"]},"route":"/institutions/isp-chile/","neighbours":{"institution":[{"id":"minsal-chile","kind":"institution","name":"Ministerio de Salud (Chile)","route":"/institutions/minsal-chile/"}]}}